Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,530 | 15,160 | 2,390 | 6,710 | 2,570 |
| Marketable Securities | 8,380 | 12,330 | 13,350 | 11,870 | 9,470 |
| Other current assets | 530 | 660 | 950 | 420 | 700 |
| TOTAL | $32,440 | $28,150 | $16,690 | $19,000 | $12,740 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 60 | 60 | 60 | 60 | 70 |
| TOTAL | $60 | $60 | $60 | $60 | $70 |
| Total Assets | $39,880 | $35,690 | $24,870 | $27,360 | $21,280 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 670 | 400 | 650 | 680 | 830 |
| Accrued Expenses | 1,100 | 1,290 | 830 | 710 | 890 |
| TOTAL | $2,160 | $2,080 | $1,830 | $1,740 | $2,060 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 4,110 | 5,060 | 5,140 | 5,240 |
| Other Non-Current Liabilities | 0 | 0 | 510 | 490 | 500 |
| TOTAL | $4,010 | $4,110 | $5,570 | $5,630 | $5,740 |
| Total Liabilities | $6,170 | $6,200 | $7,400 | $7,390 | $7,810 |
| Shareholders' Equity | |||||
| Common Shares | 600 | 560 | 550 | 540 | 530 |
| Retained earnings | -219,480 | -214,430 | -209,180 | -205,930 | -211,130 |
| Other shareholders' equity | 0 | 0 | -10 | -40 | -50 |
| TOTAL | $33,700 | $29,490 | $17,470 | $19,970 | $13,470 |
| Total Liabilities And Equity | $39,870 | $35,690 | $24,870 | $27,360 | $21,280 |